These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 7911010

  • 41. Comparison of terfenadine once daily with terfenadine twice daily for the treatment of perennial allergic rhinitis.
    Rosario NA.
    J Int Med Res; 1991; 19(2):112-20. PubMed ID: 1677901
    [Abstract] [Full Text] [Related]

  • 42. Azelastine nasal spray in the management of seasonal allergic rhinitis.
    Meltzer EO, Weiler JM, Dockhorn RJ, Widlitz MD, Freitag JJ.
    Ann Allergy; 1994 Apr; 72(4):354-9. PubMed ID: 7908778
    [Abstract] [Full Text] [Related]

  • 43. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.
    Horak F, Zieglmayer UP, Zieglmayer R, Kavina A, Marschall K, Munzel U, Petzold U.
    Curr Med Res Opin; 2006 Jan; 22(1):151-7. PubMed ID: 16393441
    [Abstract] [Full Text] [Related]

  • 44. [Ebastine vs terfenadine in allergic rhinitis].
    Terán Ortíz L, Flores Sandoval G, Orea Solano M, Camarena A.
    Rev Alerg; 1993 Jan; 40(4):82-5. PubMed ID: 7908244
    [Abstract] [Full Text] [Related]

  • 45. [Investigation of the efficacy and tolerability of azelastine nasal spray versus ebastine tablets in patients with seasonal allergic rhinitis].
    Antépara I, Jaúregui I, Basomba A, Cadahia A, Feo F, García JJ, Gonzalo MA, Luna I, Rubio M, Vázquez M.
    Allergol Immunopathol (Madr); 1998 Jan; 26(1):9-16. PubMed ID: 9585822
    [Abstract] [Full Text] [Related]

  • 46. Vasomotor rhinitis: clinical efficacy of azelastine nasal spray in comparison with placebo.
    Gehanno P, Deschamps E, Garay E, Baehre M, Garay RP.
    ORL J Otorhinolaryngol Relat Spec; 2001 Jan; 63(2):76-81. PubMed ID: 11244365
    [Abstract] [Full Text] [Related]

  • 47. Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in patients with seasonal allergic rhinitis.
    Bernstein JA, Prenner B, Ferguson BJ, Portnoy J, Wheeler WJ, Sacks HJ.
    Am J Rhinol Allergy; 2009 Jan; 23(5):512-7. PubMed ID: 19807985
    [Abstract] [Full Text] [Related]

  • 48. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
    Bernstein JA.
    Curr Med Res Opin; 2007 Oct; 23(10):2441-52. PubMed ID: 17723160
    [Abstract] [Full Text] [Related]

  • 49. Meta-analysis of azelastine nasal spray for the treatment of allergic rhinitis.
    Lee TA, Pickard AS.
    Pharmacotherapy; 2007 Jun; 27(6):852-9. PubMed ID: 17542768
    [Abstract] [Full Text] [Related]

  • 50. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
    Hampel FC, Ratner PH, Van Bavel J, Amar NJ, Daftary P, Wheeler W, Sacks H.
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
    [Abstract] [Full Text] [Related]

  • 51. Azelastine and olopatadine in the treatment of allergic rhinitis.
    Kaliner MA.
    Ann Allergy Asthma Immunol; 2009 Nov; 103(5):373-80. PubMed ID: 19927534
    [Abstract] [Full Text] [Related]

  • 52. Azelastine nasal spray for allergic rhinitis.
    Med Lett Drugs Ther; 1997 May 09; 39(1000):45-7. PubMed ID: 9150688
    [No Abstract] [Full Text] [Related]

  • 53. A multicenter clinical study of the efficacy and tolerability of azelastine nasal spray in the treatment of seasonal allergic rhinitis: a comparison with oral cetirizine.
    Charpin D, Godard P, Garay RP, Baehre M, Herman D, Michel FB.
    Eur Arch Otorhinolaryngol; 1995 May 09; 252(8):455-8. PubMed ID: 8719584
    [Abstract] [Full Text] [Related]

  • 54. Azelastine and fluticasone nasal spray: any advantage?
    Drug Ther Bull; 2014 Feb 09; 52(2):21-4. PubMed ID: 24504481
    [Abstract] [Full Text] [Related]

  • 55. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
    Noble S, McTavish D.
    Drugs; 1995 Dec 09; 50(6):1032-49. PubMed ID: 8612470
    [Abstract] [Full Text] [Related]

  • 56. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
    Carr WW, Ratner P, Munzel U, Murray R, Price D, Canonica GW, Mullol J, Virchow JC, Lieberman P, Meltzer E, Bachert C.
    Allergy Asthma Proc; 2012 Dec 09; 33(6):450-8. PubMed ID: 23127291
    [Abstract] [Full Text] [Related]

  • 57. Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis.
    Dockhorn R, Aaronson D, Bronsky E, Chervinsky P, Cohen R, Ehtessabian R, Finn A, Grossman J, Howland W, Kaiser H, Pearlman D, Sublett J, Ratner P, Settipane G, Sim T, Storms W, Webb R, Drda K, Wood C.
    Ann Allergy Asthma Immunol; 1999 Apr 09; 82(4):349-59. PubMed ID: 10227333
    [Abstract] [Full Text] [Related]

  • 58. Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis.
    Golden S, Teets SJ, Lehman EB, Mauger EA, Chinchilli V, Berlin JM, Kakumanu S, Lucus T, Craig TJ.
    Ann Allergy Asthma Immunol; 2000 Jul 09; 85(1):53-7. PubMed ID: 10923605
    [Abstract] [Full Text] [Related]

  • 59. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis.
    Lockey RF, Widlitz MD, Mitchell DQ, Lumry W, Dockhorn R, Woehler T, Grossman J.
    Ann Allergy Asthma Immunol; 1996 May 09; 76(5):448-54. PubMed ID: 8630719
    [Abstract] [Full Text] [Related]

  • 60. A multicenter randomized double-blind 2-week comparison study of azelastine nasal spray 0.1% versus levocabastine nasal spray 0.05% in patients with moderate-to-severe allergic rhinitis.
    Han D, Chen L, Cheng L, Liu S, Fu Z, Zhang W, Wang C, Xi L, Zhang L, Chinese Allergic Rhinitis Collaborative Research Group (C2AR2G).
    ORL J Otorhinolaryngol Relat Spec; 2011 May 09; 73(5):260-5. PubMed ID: 21832863
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.